Randomized Controlled Open-Label Non-Inferiority Trial Comparing Day 5 Embryos Derived From Intravaginal Culture Using the Medical Device INVOcell to Traditional In Vitro Fertilization
The purpose of this study is to evaluate intravaginal culture using the medical device INVOcell to generate day 5 blastocysts in comparison to traditional IVF.
100 Clinical Results associated with Invaron Pharmaceuticals, Inc.
0 Patents (Medical) associated with Invaron Pharmaceuticals, Inc.
100 Deals associated with Invaron Pharmaceuticals, Inc.
100 Translational Medicine associated with Invaron Pharmaceuticals, Inc.